Article information
Full text is only aviable in PDF
REFERENCES
[1]
M Angell.
The truth about the drug companies: how they deceive us and what to do about it, Casa Al Azar, (2004),
[2]
K Abbasi, R Smith.
No more free lunches.
BMJ, 326 (2003), pp. 1155-1156
[3]
R Moynihan.
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement.
BMJ, 326 (2003), pp. 1189-1192
[4]
R Moynihan.
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement.
BMJ, 326 (2003), pp. 1193-1196
[5]
F Savater.
Ética para Amador, 45th ed., Ariel, (2004),
[6]
Caballé C. Declaraciones al periódico Expansión. Barcelona, 2004, 30 de septiembre.
[7]
F Davidoff, CD de Angelis, JM Drazen, J Hoey, L Hojgaard, R Horton, et al.
Sponsorship, authorship, and accountability.
Lancet, 358 (2001), pp. 854-856
[8]
J Collier, I Iheanacho.
The pharmaceutical industry as an informant.
Lancet, 369 (2002), pp. 1405-1409
[9]
E Wager.
How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.
BMJ, 326 (2003), pp. 1196-1198
[10]
A Figueras, JR Laporte.
Failures of the therapeutic chain as a cause of drug ineffectiveness. Promotion, misinformation, and economics work better than needs.
BMJ, 326 (2003), pp. 895-896
[11]
JK Galbraith.
La cultura de la satisfacción, 7th ed., Ariel, (1997),
[12]
A Liberati, N Magrini.
Information from drug companies and opinion leaders.
BMJ, 326 (2003), pp. 1156-1157
[13]
PA Rochon, JH Gurwitz, M Cheung, JA Hayes, TC Chalmers.
Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal.
JAMA, 272 (1994), pp. 108-113
[14]
B Spilker, P Cuatrecasas.
La industria farmacéutica: una visión interior, Prous Science Publishers, (1992),
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
